Enalapril and ASS inhibit tumor growth in a transgenic mouse model of islet cell tumors

ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Functional Pancreatic Endocrine Tumor Syndromes

(2012) Robert T. Jensen et al.   NEUROENDOCRINOLOGY

Hedgehog Inhibition With the Orally Bioavailable Smo Antagonist LDE225 Represses Tumor Growth and Prolongs Survival in a Transgenic Mouse Model of Islet Cell Neoplasms

(2011) Volker Fendrich et al.   ANNALS OF SURGERY

Hedgehog Inhibition With Cyclopamine Represses Tumor Growth and Prolongs Survival in a Transgenic Mouse Model of Islet Cell Tumors

(2011) Volker Fendrich et al.   ANNALS OF SURGERY

The renin–angiotensin system in the breast and breast cancer

(2011) Gavin P Vinson et al.   ENDOCRINE-RELATED CANCER

Is there an optimal combination of antihypertensives for preventing cardiovascular events?

(2011) Koon K. Teo   JOURNAL OF HYPERTENSION

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors

(2011) Eric Raymond et al.   NEW ENGLAND JOURNAL OF MEDICINE

Everolimus for Advanced Pancreatic Neuroendocrine Tumors

(2011) James C. Yao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Changes in the renin angiotensin system during the development of colorectal cancer liver metastases

(2010) Jaclyn H Neo et al.   BMC CANCER

Inhibition of renin–angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine

(2010) Y Nakai et al.   BRITISH JOURNAL OF CANCER

Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials

(2010) Ilke Sipahi et al.   LANCET ONCOLOGY

Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials

(2010) Sripal Bangalore et al.   LANCET ONCOLOGY

Unknown

(2009) Emilio Bajetta et al.   CLINICAL THERAPEUTICS

The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer

(2009) V. Fendrich et al.   GUT

Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy

(2009) Stefan Wilop et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Role of NF-κB in thyroid cancer

(2009) Francesco Pacifico et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist

(2009) D. R. Rhodes et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Screening of Patients with Multiple Endocrine Neoplasia Type 1 (MEN-1): A Critical Analysis of Its Value

(2009) Jens Waldmann et al.   WORLD JOURNAL OF SURGERY

Risk Factors and Causes of Death in MEN1 Disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) Cohort Study Among 758 Patients

(2009) Pierre Goudet et al.   WORLD JOURNAL OF SURGERY

Thymic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: A Comparative Study on 21 Cases Among a Series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines)

(2009) Pierre Goudet et al.   WORLD JOURNAL OF SURGERY

Hedgehog Signaling Is Required for Effective Regeneration of Exocrine Pancreas

(2008) Volker Fendrich et al.   GASTROENTEROLOGY

Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors

(2008) David C. Metz et al.   GASTROENTEROLOGY